Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BREXPIPRAZOLE Cause Hepatic function abnormal? 22 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hepatic function abnormal have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.2% of all adverse event reports for BREXPIPRAZOLE.

22
Reports of Hepatic function abnormal with BREXPIPRAZOLE
0.2%
of all BREXPIPRAZOLE reports
2
Deaths
7
Hospitalizations

How Dangerous Is Hepatic function abnormal From BREXPIPRAZOLE?

Of the 22 reports, 2 (9.1%) resulted in death, 7 (31.8%) required hospitalization, and 1 (4.5%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does BREXPIPRAZOLE Cause?

Weight increased (1,589) Product use in unapproved indication (1,188) Off label use (937) Akathisia (807) Drug ineffective (730) Tardive dyskinesia (558) Tremor (552) Anxiety (475) Product use issue (434) Suicidal ideation (427)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which BREXPIPRAZOLE Alternatives Have Lower Hepatic function abnormal Risk?

BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL BREXPIPRAZOLE vs BRIGATINIB BREXPIPRAZOLE vs BRILINTA BREXPIPRAZOLE vs BRILIQUE BREXPIPRAZOLE vs BRIMONIDINE

Related Pages

BREXPIPRAZOLE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal BREXPIPRAZOLE Demographics